Related Experiment Video
Updated: Jan 6, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases
Martyna Godzieba1, Slawomir Ciesielski1
1Department of Environmental Biotechnology, Faculty of Environmental Sciences, University of Warmia and Mazury in Olsztyn, ul. Sloneczna 45 G, 10-917 Olsztyn, Poland.
Abstract:
Cancer and infectious diseases are one of the greatest challenges of modern medicine. An unhealthy lifestyle, the improper use of drugs, or their abuse are conducive to the increase of morbidity and mortality caused by these diseases. The imperfections of drugs currently used in therapy for these diseases and the increasing problem of drug resistance have forced a search for new substances with therapeutic potential. Throughout history, plants, animals, fungi and microorganisms have been rich sources of biologically active compounds. Even today, despite the development of chemistry and the introduction of many synthetic chemotherapeutics, a substantial part of the new compounds being tested for treatment are still of natural origin. Natural compounds exhibit a great diversity of chemical structures, and thus possess diverse mechanisms of action and molecular targets. Nucleic acids seem to be a good molecular target for substances with anticancer potential in particular, but they may also be a target for antimicrobial compounds. There are many types of interactions of small-molecule ligands with DNA. This publication focuses on the intercalation process. Intercalators are compounds that usually have planar aromatic moieties and can insert themselves between adjacent base pairs in the DNA helix. These types of interactions change the structure of DNA, leading to various types of disorders in the functioning of cells and the cell cycle. This article presents the most promising intercalators of natural origin, which have aroused interest in recent years due to their therapeutic potential.
Insights
Natural compounds, particularly DNA intercalators, offer promising therapeutic potential for combating cancer and infectious diseases due to their diverse structures and mechanisms. This research highlights natural intercalators as novel drug candidates against drug-resistant pathogens and cancer.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Molecular Biology
Background:
- Cancer and infectious diseases pose significant global health challenges, exacerbated by lifestyle factors and increasing drug resistance.
- Current therapies face limitations, driving the need for novel therapeutic agents with unique mechanisms of action.
- Natural products have historically been and remain a vital source of diverse, biologically active compounds for drug discovery.
Purpose of the Study:
- To explore the therapeutic potential of natural compounds as anticancer and antimicrobial agents.
- To focus on DNA intercalators, a class of compounds that interact with nucleic acids.
- To present promising natural intercalators that have garnered recent research interest.
Main Methods:
- Review of scientific literature on natural product chemistry and pharmacology.
- Focus on compounds exhibiting DNA intercalation as a mechanism of action.
- Analysis of chemical structures and biological activities of identified natural intercalators.
Main Results:
- Natural compounds possess diverse chemical structures and mechanisms, targeting various molecular pathways.
- DNA intercalation represents a key interaction for anticancer and antimicrobial activity.
- Several natural intercalators demonstrate significant therapeutic potential against challenging diseases.
Conclusions:
- Natural intercalators are promising candidates for developing new treatments against cancer and infectious diseases.
- Their unique ability to interact with DNA offers a strategy to overcome existing drug resistance.
- Further research into natural intercalators could lead to novel chemotherapeutics.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
10:05Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
Related Concept Videos
Non-LTR Retrotransposons
Targeted Cancer Therapies
There are several types of targeted therapies against...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Microorganisms in Medicine and Therapeutics
DNA Helicases